AzTrials
AzTrials

Non-carious Cervical LesionsNCT01947192

Chlorhexidine as Coadjuvant in Dentin Adhesion of Noncarious Cervical Lesions

A study testing Treatment with chlorhexidine and Water pre-treatment in people with Non-carious Cervical Lesions, run by Federal University of Pelotas at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the effect of chlorhexidine digluconate (CRX) application in etched dentin on the retention of noncarious cervical lesions restorations. A randomized controlled split-mouth and blind trial will be carried out. Patients with at least two non-carious cervical lesions (NCL) will be selected. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Non-carious Cervical Lesions
What is being tested?
Treatment with chlorhexidine and Water pre-treatment
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
50 participants
Where
1 siteBrazil
Study dates
Nov 2011to Nov 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients presenting at least two non-carious cervical lesions (NCL) in anterior, canine or pre-molars;
  • Patients who had more than 20 teeth in the mouth;
  • Patients who were at least 18 years of age at the time of treatment and capable to understand and sign the written informed consent;
  • NCL with at least 1 mm of depth in a vital permanent incisor, canine or premolar of the upper as the lower jaw.
  • NCL in the facial surface of the teeth with sometimes a small part extending interproximally;
  • Patients with good periodontal heath.

Who cannot join

  • Patients with smoking habits, practicing bruxism, severe systemic diseases, using active orthodontic treatment, malocclusion (Angle Class II or Class III);
  • Tooth with the NCL with the absent of antagonist;
  • NCL wear facets upper than 50% of the incisal/occlusion surface, as a result of tooth attrition;
  • Presence of caries or restorations in the area to be treated;
  • Full-mouth visible plaque index (VPI) or full-mouth gingival bleeding index upper than 20%, probing depth and clinical attachment loss values exceeding 4 mm with bleeding on probing;
  • Unwillingness to return for follow-ups or refuse to participate.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • School of Dentistry, Federal University of Pelotas

    Pelotas, Rio Grande do Sul, 96015-560

Other trials in Brazil

About this study

Official title: Chlorhexidine as Coadjuvant in Dentin Adhesion of Noncarious Cervical Lesions and Failure-prognostic Variables: A Randomized Controlled Trial

This study aims to evaluate the effect of chlorhexidine digluconate (CRX) application in etched dentin on the retention of noncarious cervical lesions restorations.

A randomized controlled split-mouth and blind trial will be carried out. Patients with at least two non-carious cervical lesions (NCL) will be selected. NCL will be randomly assigned according the type of teeth (incisors, canine or pre-molars) into two groups: control or experimental group (application of 2% CRX for 60 seconds after the acid etching procedure). Class V restorations will be performed out with an etch-and-rinse adhesive system (Adper Single Bond 2-3M ESPE) and a composite resin (Filtek Z350-3M ESPE) according the manufacture instructions, by previously trained operators. The restorations will be evaluated by a calibrate examiner at 1 week (baseline), and 6-month, 12-month and 24-month, using the World Dental Federation (FDI) criteria. The outcome is retention of the restoration.

Being tested
Treatment with chlorhexidine, Water pre-treatment
Keywords
Chlorhexidine, Matrix metalloproteinases (MMP) inhibitor, Adhesive system, Controlled clinical trial, Dental restoration, Noncarious cervical lesions, Dental restoration failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treatment with chlorhexidineProcedure or surgery

    Application of 2% chlorhexidine digluconate (60 seconds) after the etching procedure and before the adhesive system.

  • Water pre-treatmentProcedure or surgery

    Treatment of acid etched dentin with sterilized water for 60 s before adhesive system application

Study groups in NCT01947192
Study groupRoleWhat they receive
ChlorhexidineExperimentalDentin pre-treatment with a experimental solution (chlorhexidine), after the dentin acid etching
Receives: Procedure: Treatment with chlorhexidine
WaterPlacebo comparatorApplication of water (placebo) after dentin acid etching.
Receives: Procedure: Water pre-treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in Retention rates of the restoration at 24 months

    Patients will be reevaluated at each specified time point and all restoration sites will be evaluated to check if the restoration will be still in place, or if it is missing, or if there is partial retention

    Measured: 6, 12 and 24 months

Secondary outcomes (2)
  1. Change from baseline in Post-operative sensitivity at 6-month

    At each time-point, patients will be recalled and interviewed regarding any symptom related to each restorations placed.

    Measured: baseline and 6-month

  2. Change from baseline in marginal staining rates at 6. 12 and 24 months

    At each time-point, patients will be recalled and restorations will be reassessed in order to record changes in the rates of marginal staining, using the World Dental Federation (FDI) criteria for restorations assessment (Hickel et al 2010).

    Measured: 6, 12 and 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Sep 2013 (estimated)
  2. Study startNov 2011
  3. Primary completionNov 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01947192
Sponsor's protocol ID
PPGO0017
Status last verified
Feb 2016
First submitted
15 Aug 2013
Last updated
24 Feb 2016
Results posted
No

Publications

  • Hickel R, Peschke A, Tyas M, Mjor I, Bayne S, Peters M, Hiller KA, Randall R, Vanherle G, Heintze SD. FDI World Dental Federation: clinical criteria for the evaluation of direct and indirect restorations-update and clinical examples. Clin Oral Investig. 2010 Aug;14(4):349-66. doi: 10.1007/s00784-010-0432-8. Epub 2010 Jul 14.

    PubMed 20628774

Questions about this trial

What is this clinical trial studying?

A study testing Treatment with chlorhexidine and Water pre-treatment in people with Non-carious Cervical Lesions, run by Federal University of Pelotas at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in Retention rates of the restoration at 24 months (time frame: 6, 12 and 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01947192, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in